FDA Inspection
Pfizer Pharmaceuticals LLC-PiperacillinPfizer Pharmaceuticals LLC-Piperacillin – FDA Inspection, Feb 3, 2012
Record Details
This FDA Inspection record concerns Pfizer Pharmaceuticals LLC-Piperacillin, with an inspection on February 3, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 3, 2012
- Product Type
- Drugs
View Company Profile
ID · 1da439ce-55f3-4408-8d39-a42325ef13a0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 766147
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.50Sewage and refuse disposal in safe manner
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.56(b)Written sanitation procedures not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer Pharmaceuticals LLC-Piperacillin
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Pharmaceuticals LLC-Piperacillin
- FDA Inspection 681751 - 2010-09-15
- FDA Inspection 602563 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.